Membrane crystallization for the recovery of a pharmaceutical compound from waste streams

Abstract

The recovery of the active pharmaceutical compound 1-(5-bromo-fur-2-il)-2-bromo-2-nitroethane (denoted as G-1) in a crystalline form from waste aqueous solutions using membrane crystallization is addressed in this work. The process conditions were evaluated, observing that a low flowrate of the feed solution (5.0 ml/min) is required to crystallize G-1. In addition, the use of Vitrofural as the feed solution, which is a mixture of G-1 and PEG, allows operating with higher concentrations due to the higher solubility of Vitrofural in water. However, the presence of PEG affects the mass transfer, leading to a lower transmembrane flux compared to the use of pure G-1.

SEM images were used to evaluate the surface morphology of the crystallized G-1. It was concluded that the crystals obtained by membrane crystallization have the same morphology as the commercial G-1. Thus, the application of membrane crystallization for G-1 recovery can be considered as a novel technique with high potential to recover pharmaceutical compounds from waste streams.